Trials / Not Yet Recruiting
Not Yet RecruitingNCT06485492
Aneurysm Embolization System for Intracranial Aneurysms
Prospective, Multicenter Design of Clinical Trials to Evaluate the Safety and Efficacy of Aneurysm Embolization Systems for the Treatment of Intracranial Aneurysms, Including Ruptured Aneurysms
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Jiangsu CED Medtech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study was to evaluate the safety and efficacy of the aneurysm embolization system produced by Jiangsu Changyida Medical Technology Co., Ltd. in patients with intracranial aneurysms (including ruptured aneurysms)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Implant an aneurysm embolization system | The product uses minimally invasive interventional method to treat intracranial aneurysms approved for application. The study physician selects the appropriate size and/or shape of the aneurysm based on the size and shape of the intracranial arterioma. The aneurysm embolization system device is inserted into the arterioma through a compatible neurovascular microcatheter. |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
- First posted
- 2024-07-03
- Last updated
- 2024-07-03
Source: ClinicalTrials.gov record NCT06485492. Inclusion in this directory is not an endorsement.